Drugs / PP4001
last change Oct 2011 re-read 3 minutes ago

PP4001

Developed for
urinary tract infection
Investigated by
Pinnacle Pharmaceuticals, Inc.

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01406587 Jul → Oct 2011 urinary tract infection Pinnacle Pharmaceuticals, Inc. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PP4001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01406587 ↗